Sphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1
Open Access
- 4 April 2020
- Vol. 9 (4), 886
- https://doi.org/10.3390/cells9040886
Abstract
Cancer stem cells (CSCs) represent rare tumor cell populations capable of self-renewal, differentiation, and tumor initiation and are highly resistant to chemotherapy and radiotherapy. Thus, therapeutic approaches that can effectively target CSCs and tumor cells could be the key to efficient tumor treatment. In this study, we explored the function of SPHK1 in breast CSCs and non-CSCs. We showed that RNAi-mediated knockdown of SPHK1 inhibited cell proliferation and induced apoptosis in both breast CSCs and non-CSCs, while ectopic expression of SPHK1 enhanced breast CSC survival and mammosphere forming efficiency. We identified STAT1 and IFN signaling as key regulatory targets of SPHK1 and demonstrated that an important mechanism by which SPHK1 promotes cancer cell survival is through the suppression of STAT1. We further demonstrated that SPHK1 inhibitors, FTY720 and PF543, synergized with doxorubicin in targeting both breast CSCs and non-CSCs. In conclusion, we provide important evidence that SPHK1 is a key regulator of cell survival and proliferation in breast CSCs and non-CSCs and is an attractive target for the design of future therapies.Keywords
Funding Information
- Ministry of Higher Education, Malaysia (FRGS/1/2016/SKK08/IMU/01/1, ERGS/1/2013/SKK01/IMU/02/1)
This publication has 91 references indexed in Scilit:
- Cancer Stem Cells and Targeting StrategiesCells, 2019
- Cancer stem cells revisitedNature Medicine, 2017
- Wnt Signaling in Cancer Stem Cell BiologyCancers, 2016
- Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotypeScientific Reports, 2015
- Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like CellsCancer Research, 2015
- Notch Reporter Activity in Breast Cancer Cell Lines Identifies a Subset of Cells with Stem Cell ActivityMolecular Cancer Therapeutics, 2015
- NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cellsJCI Insight, 2014
- Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cellsCellular Signalling, 2013
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumorsJCI Insight, 2011
- Mammary Stem Cells and Breast Cancer—Role of Notch SignallingStem Cell Reviews and Reports, 2007